XML 22 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Cash Flows (USD $)
9 Months Ended 12 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating expenses:        
Net loss $ (1,136,551) $ (586,351) $ (1,247,644) $ (299,119)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Depreciation expense 1,532 903 1,412 923
Interest expense related to amortization and acceleration of debt discount 0 74,446 163,784 8,272
Interest expense related to shares issued upon settlement of convertible debt 0 0 96,600 0
Change in fair value of derivative liabilities 49,111 (9,275) (9,275) 0
Stock-based compensation 0 83,508 83,508 0
Bad debts expense 15,653 0 28,362 6,000
Cancellation of trade liabilities and unpaid interest 61,733 41,982 73,057 0
Changes in operating assets and liabilities:        
Accounts receivable (8,187) 239,149 67,644 (253,031)
Costs and estimated earnings in excess of billings on uncompleted contracts 0 (22,273) 14,036 (14,036)
Inventory (134,368) 20,171 (299,038) (42,112)
Prepaid expenses and other current assets 20,000 18,975 6,222 0
Accounts payable and accrued expenses (227,730) 83,661 82,518 (169,843)
Accrued compensation and related costs (140,310) 0 140,310 (20,254)
Accrued interest (554) 13,719 (68,521) 56,198
Billings in excess of costs and estimated earnings on uncompleted contracts on uncompleted contracts (1,800) (44,149) (82,278) 11,254
Deferred revenue 376,543 (80,989) 132,761 89,190
Related party accrued expenses (72,472) (10,117) 12,137 (19,709)
Net cash provided by (used in) operating activities (1,197,400) (176,640) (804,405) (646,267)
Cash flows used in investing activities        
Short-term investments (39,069) 0 0 0
Purchase of equipment (5,809) (1,469) (2,034) (2,591)
Net cash used in investing activities (44,878) (1,469) (2,034) (2,591)
Cash flows from financing activities:        
Cash - overdraft 0 0 0 (99,639)
Proceeds from convertible notes payable 0 95,000 95,000 660,000
Principal payments on convertible notes payable 0 0 (660,000) 0
Proceeds from short-term notes payable 0 0 41,247 60,000
Principal payments on short-term notes payable (41,247) (83,944) (255,000) (20,000)
Proceeds from related party notes payable 0 0 0 189,058
Principal payments on related party notes payable 0 (84,224) (84,224) (104,834)
Stockholder capital contributions 0 0 0 118,800
Proceeds from issuances of common stock 1,200,000 135,000 160,000 0
Purchase and retirement of common stock 0 0 (50,000) 0
Proceeds from issuance of common stock and warrants in private offering 0 0 2,443,550 0
Net cash provided by (used in) financing activities 1,158,753 61,832 1,690,573 803,385
Net increase (decrease) in cash (83,525) (116,277) 884,134 154,527
Cash and cash equivalents - beginning of year/period 1,038,661 154,527 154,527 0
Cash and cash equivalents - end of year/period 955,136 38,250 1,038,661 154,527
Cash paid during the year/period for:        
Interest 0 10,881 129,033 14,505
Supplemental disclosure of non-cash information:        
Conversion of debt to common stock $ 0 $ 0 $ 95,000 $ 0